BackFirst Wave BioPharma Overview

First Wave BioPharma Other Liabilities

First Wave BioPharma's other liabilities is $0.

Get informed when a big investor buys or sells

+ Follow
Other Liabilities
$0.00

Peer average

Loading

First Wave BioPharma Other Liabilities History

Loading

First Wave BioPharma vs. peers: Other Liabilities Comparison

Loading

First Wave BioPharma Other Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

First Wave BioPharma (FWBI) FAQ

First Wave BioPharma posts a other liabilities of $0 as of June 2026. In the prior-year period, the figure was $0. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, First Wave BioPharma's other liabilities was $0. The latest reading is $0 (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

Other Liabilities is one piece of First Wave BioPharma's financial statement story. At $0, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for FWBI's other liabilities usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; First Wave BioPharma's other metric pages and overview cover the third.

Judging First Wave BioPharma against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in other liabilities easier to interpret. Start with $0 here, then scan peer and history charts to see if the gap is persistent.